Russian Military   Report issue

Government Phase 2 Phase 3
Founded: Russian Federation (1992)

Organization Overview

First Clinical Trial
2013
NCT02104830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Federal state budgetary institution " Main military clinical hospital named after academician N. N. Burdenko " of the Ministry of Defence of the Russian Federation | Military Medical Academy named after SM Kirov, the Russian Defense Ministry, 2nd Department and Clinic of medical postrgaduate education

Active Ingredients

Drugs in Phase 3 Trials (2)

Pegfilgrastim (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Phase 2 Trials (2)

gamfluvac (2 trials)

sodium succinate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 2)

Influenza, Human (Phase 1)

Liver Diseases (Phase 2)

Neutropenia (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 2)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4